KIN-001

N/A

Report date: 2024/09/04 13:56:20
NME

Base Information

Drug NameKIN-001
Drug Alias NamePioglitazone/pamapimodKINFASTKIN-001KIN001-AMDKIN001-IPF
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 mitogen-activated protein kinase inhibitorsPeroxisome proliferator activated receptor agonistsPeroxisome proliferator-activated receptor γ agonists
TargetsP38 mitogen-activated protein kinasePeroxisome proliferator activated receptorPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Macular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanySwitzerland
CombinationsYes PamapimodPioglitazone Hydrochloride
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKinarus Ag
China Registration ClassN/A

Develop Information

Active CompaniesKinarus Ag
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A